Specify a stock or a cryptocurrency in the search bar to get a summary
Themis Medicare Limited
THEMISMEDThemis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India. Address: 11/12 Udyog Nagar Industrial Estate, Mumbai, India, 400104
Analytics
WallStreet Target Price
–P/E ratio
49.0129Dividend Yield
0.19 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures THEMISMED
Dividend Analytics THEMISMED
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
44 %Dividend History THEMISMED
Stock Valuation THEMISMED
Financials THEMISMED
Results | 2019 | Dynamics |